Giulia Sapuppo

6PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Women's studies (incl. girls' studies)Predictive and prognostic markersAdolescent healthMedical and biological physics not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 29, 2025
Therapeutic Efficacy of a Very Low/Low Dose of Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer: A Real-World Series from a Single Center.

Vittorio Oteri, Fiorenza Gianì, Giulia Sapuppo

|Apr 08, 2025
Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study).

Giulia Puliani, Marta Bianchini, Carlotta Giani

|Sep 12, 2022
Is multifocality a risk factor in low-risk papillary thyroid cancer?

Giulia Sapuppo, Sonia Grasso, Guenda Di Benedetto

|Sep 28, 2021
Risk of Benign and Malignant Thyroid Disorders in Subjects Treated for Paediatric/Adolescent Neoplasia: Role of Morphological and Functional Screening.

Giulia Sapuppo, Martina Tavarelli, Emanuela Cannata

|Aug 07, 2021
Differentiated Thyroid Cancer in Children and Adolescents: Long Term Outcome and Risk Factors for Persistent Disease.

Giulia Sapuppo, Dana Hartl, Brice Fresneau

|Jun 30, 2020
Giant parathyroid adenoma: a rare cause of primary hyperparathyroidism mimicking a carcinoma.

Giuseppe Evola, Martina Tavarelli, Francesco Roberto Evola

Pageof 1

Frequent Collaborators

3 joint publications

Gabriella Pellegriti

1 joint publications

Giuseppe Evola

1 joint publications

Francesco Roberto Evola

1 joint publications

Brice Fresneau